ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Accepts Arcutis Biotherapeutics’ New Drug Application for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
December 27, 2021Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration’s (FDA)... -
Arcutis Announces Additions to its Investor Relations and Communications Team
August 03, 2021Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company,today announced leadership additions to investor relations and communications functions.
Pharma Sources Insight January 2025
